B4GALT1 and neoplasm: Functionally, B4GALT1 promotes chemoresistance in PDAC via NF-κB-mediated upregulation and stabilization of CDK11^p110 through glycosylation, leading to tumor growth and gemcitabine resistance (Ding et al., 2021).